Outcomes Data of Adipose Stem Cells to Treat Parkinson's Disease

StemGenex

Status: Unknown

Conditions: Parkinson's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT02184546

ASCPD-01

SVF01PD

Details and patient eligibility

About

The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on the quality of life of people with Parkinson's disease (PD). SVF contains components with "regenerative" properties, including stem cells that may be capable of ameliorating specific disease conditions. This study is designed to evaluate quality of life changes in individuals with PD for up to 12 months following SVF treatment.

Enrollment: 75 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects scheduled for a stem cell/SVF treatment
• Subjects diagnosed with idiopathic Parkinson's disease
• Subjects ages 18 years and older
• Subjects willing and able to sign informed consent
• Subjects willing and able to perform follow up interviews and surveys

Exclusion criteria

• Subjects with additional major health diagnoses
• Subjects that are pregnant or breastfeeding